Right atrial pacing in coronary heart disease

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Atherosclerosis·2001

Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.

Thrombosis and haemostasis·2000

Heart rate variability and progression of coronary atherosclerosis.

Arteriosclerosis, thrombosis, and vascular biology·1999

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

Circulation·1998

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.

Atherosclerosis·1998

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

The Journal of clinical investigation·1998

Challenges in atrial fibrillation.

Advances in cardiology·2012

Antiplatelet therapy in stroke prevention.

Advances in cardiology·2012

Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.

Advances in cardiology·2012

Stents and antiplatelet therapy.

Advances in cardiology·2012

Genetic considerations.

Advances in cardiology·2012

Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndrome.

Advances in cardiology·2012

Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity.

Acta physiologica (Oxford, England)·2026

PCI for in-stent restenosis of an anomalous right coronary artery.

Annales de cardiologie et d'angeiologie·2026

Prophylactic implantation of implantable cardioverter-defibrillator for the primary prevention of sudden cardiac death after myocardial infarction: protocol for systematic review and meta-analysis of randomised controlled trials.

BMJ open·2026

Direct oral anticoagulants in elderly patients with atrial fibrillation: a decade-long nationwide retrospective cohort study.

BMJ open·2026

Calcium handling in post-infarction arrhythmias - evidence from large animals.

American journal of physiology. Heart and circulatory physiology·2026

Iron Deficiency and Bone Metabolism in Heart Failure.

European journal of heart failure·2026

Related Experiment Videos

Right atrial pacing in coronary heart disease

Related Concept Videos

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.

Heart rate variability and progression of coronary atherosclerosis.

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Challenges in atrial fibrillation.

Antiplatelet therapy in stroke prevention.

Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.

Stents and antiplatelet therapy.

Genetic considerations.

Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndrome.

Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity.

PCI for in-stent restenosis of an anomalous right coronary artery.

Prophylactic implantation of implantable cardioverter-defibrillator for the primary prevention of sudden cardiac death after myocardial infarction: protocol for systematic review and meta-analysis of randomised controlled trials.

Direct oral anticoagulants in elderly patients with atrial fibrillation: a decade-long nationwide retrospective cohort study.

Calcium handling in post-infarction arrhythmias - evidence from large animals.

Iron Deficiency and Bone Metabolism in Heart Failure.

Related Experiment Videos

Right atrial pacing in coronary heart disease

Related Concept Videos

Related Articles